Upstream Bio (UPB) Restructuring Costs (2024 - 2026)

Upstream Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Restructuring Costs rose 5.6% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.6 million (up 77.37% YoY), while the FY2025 annual figure was $4.5 million, up 127.77% from the prior year.
• Restructuring Costs was $1.1 million for Q1 2026 at Upstream Bio, down from $1.3 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $1.3 million in Q4 2025 to a low of $334000.0 in Q2 2024.
• Historically, Restructuring Costs has averaged $843666.7 across 3 years, with a median of $891000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs surged 273.95% in 2025, then gained 5.6% in 2026.
• A 3-year view of Restructuring Costs shows it stood at $836000.0 in 2024, then jumped by 56.58% to $1.3 million in 2025, then fell by 14.97% to $1.1 million in 2026.
• The last three Restructuring Costs figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $891000.0 (Q3 2025), per Business Quant data.